Eylea Provider Portal

Health And Fitness Careers Personal Finance Family And Parenting Business

The best matching results for Eylea Provider Portal are listed below, along with top pages, social handles, current status, FAQs, and comments. If you are facing any issues, please write detail in the comments section for the solution.

Updated: April 28, 2022

Service Status Graph

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Eylea.us

Most Visited Official Pages

Financial Support
See an overview of Wet AMD
Sign up
EYLEA® (aflibercept) Injection

Social Handles

FAQs

1

How do I bill EYLEA?

For billing purposes, use CPT 67028 to report the intravitreal injection and C9291 or J3590 to report the supply of Eylea; the former HCPCS code applies to facilities, while the latter code applies to physician's offices.
2

Who distributes EYLEA?

Based on the co-promotion agreement for EYLEA in Japan concluded on May 7, 2012, Santen distributes the product. Bayer Yakuhin and Santen both provide EYLEA drug information to healthcare professionals.
3

Is EYLEA approved in Canada?

In Canada, EYLEA® is approved for five indications including the treatment of neovascular (wet) age-related macular degeneration (AMD), the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO), the treatment of visual impairment due to macular edema secondary to branch ...
4

Is Eylea FDA approved?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration ( FDA ) has approved EYLEA® (aflibercept) Injection to treat all stages of diabetic retinopathy (DR), and thereby reduce the risk of blindness.
5

How much does an Eylea shot cost?

The cost for Eylea intravitreal solution (40 mg/mL) is around $1,941 for a supply of 0.05 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
6

What drug company makes Eylea?

EYLEA® (aflibercept) Injection by Regeneron.
7

When was Eylea approved by the FDA?

FDA approves Eylea for wet age-related macular degeneration. November 18, 2011.
2. Eyleareportingportal.com

EYLEA Reporting Portal

https://www.eyleareportingportal.com/

The EYLEA® (aflibercept) Reporting Portal is a Web-based reporting tool for Regeneron internal use only that will enable you to view the status of all ...

0
DISLIKE
REPORT

Similar Portals

Report Portal Issue

If Eylea Provider Portal is not working properly, share the problem detail below.

Your form was successfully submitted.
There was an error sending your form. Please try it again.